This study will focus on enhancing future smoking cessation treatment effectiveness by
piloting a potentially more powerful combination of three FDA-approved pharmacotherapies:
varenicline plus combination of two types of nicotine replacement therapy (NRT) treatment
(nicotine lozenge and nicotine patch). Data from this pilot study will help inform the design
of future studies that would use this combination treatment as a cessation tool within the
chronic care arsenal of treatments.